BioSig Technologies (BSGM) Competitors $0.57 -0.01 (-0.86%) Closing price 04/17/2025 03:58 PM EasternExtended Trading$0.60 +0.03 (+4.35%) As of 04/17/2025 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. DXR, SPAI, OM, MODD, POCI, FEMY, CLGN, MDAI, COCH, and PYPDShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include Daxor (DXR), Safe Pro Group Inc. Common Stock (SPAI), Outset Medical (OM), Modular Medical (MODD), Precision Optics (POCI), Femasys (FEMY), CollPlant Biotechnologies (CLGN), Spectral AI (MDAI), Envoy Medical (COCH), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. Daxor Safe Pro Group Inc. Common Stock Outset Medical Modular Medical Precision Optics Femasys CollPlant Biotechnologies Spectral AI Envoy Medical PolyPid Daxor (NASDAQ:DXR) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, community ranking, risk, valuation, dividends and media sentiment. Which has stronger earnings and valuation, DXR or BSGM? Daxor has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaxor$2.13M16.82N/AN/AN/ABioSig Technologies$39K254.11-$29.04MN/AN/A Does the MarketBeat Community prefer DXR or BSGM? BioSig Technologies received 101 more outperform votes than Daxor when rated by MarketBeat users. However, 100.00% of users gave Daxor an outperform vote while only 70.55% of users gave BioSig Technologies an outperform vote. CompanyUnderperformOutperformDaxorOutperform Votes2100.00% Underperform VotesNo VotesBioSig TechnologiesOutperform Votes10370.55% Underperform Votes4329.45% Which has more risk and volatility, DXR or BSGM? Daxor has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Is DXR or BSGM more profitable? Daxor has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. Company Net Margins Return on Equity Return on Assets DaxorN/A N/A N/A BioSig Technologies -44,832.50%N/A -776.49% Do insiders and institutionals hold more shares of DXR or BSGM? 1.3% of Daxor shares are held by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are held by institutional investors. 59.0% of Daxor shares are held by insiders. Comparatively, 17.0% of BioSig Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer DXR or BSGM? In the previous week, Daxor had 3 more articles in the media than BioSig Technologies. MarketBeat recorded 5 mentions for Daxor and 2 mentions for BioSig Technologies. Daxor's average media sentiment score of 0.13 beat BioSig Technologies' score of 0.00 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioSig Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate DXR or BSGM? Daxor presently has a consensus target price of $25.00, suggesting a potential upside of 237.38%. BioSig Technologies has a consensus target price of $2.75, suggesting a potential upside of 378.26%. Given BioSig Technologies' higher possible upside, analysts plainly believe BioSig Technologies is more favorable than Daxor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryDaxor beats BioSig Technologies on 7 of the 12 factors compared between the two stocks. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.91M$3.10B$5.30B$7.35BDividend YieldN/A1.78%5.12%4.31%P/E RatioN/A14.8721.7717.77Price / Sales254.1143.57379.4097.65Price / CashN/A44.0938.2634.64Price / Book-1.743.336.443.98Net Income-$29.04M$94.03M$3.21B$247.44M7 Day Performance-0.90%-0.08%2.82%1.82%1 Month Performance-12.75%-8.14%-8.67%-6.98%1 Year Performance-62.66%-20.18%11.38%1.49% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig Technologies1.4122 of 5 stars$0.58-0.9%$2.75+378.3%-64.7%$9.91M$39,000.000.0050Gap DownDXRDaxor4.0225 of 5 stars$7.45-2.5%$25.00+235.6%-22.9%$36.04M$2.13M0.0037Short Interest ↓News CoverageSPAISafe Pro Group Inc. Common StockN/A$2.35+44.5%N/AN/A$35.65M$2.17M0.0011OMOutset Medical1.1105 of 5 stars$9.58-12.0%$48.75+408.9%-66.0%$34.44M$113.69M-3.86520High Trading VolumeMODDModular Medical0.7063 of 5 stars$0.80-9.1%N/A-47.8%$32.53MN/A-1.5120Short Interest ↑Negative NewsPOCIPrecision Optics0.955 of 5 stars$4.15-1.3%N/A-28.2%$31.66M$18.68M-6.4880Short Interest ↓Gap DownFEMYFemasys1.9444 of 5 stars$1.15-3.4%$11.50+900.0%-4.6%$31.22M$1.63M-1.4230CLGNCollPlant Biotechnologies1.8757 of 5 stars$2.40-2.4%$12.50+420.8%-53.9%$27.49M$515,000.00-1.5670MDAISpectral AI2.1907 of 5 stars$1.18-2.5%$4.75+302.5%-35.1%$27.43M$27.26M-1.8283Short Interest ↑Gap UpCOCHEnvoy Medical1.319 of 5 stars$1.28-10.2%$9.00+605.9%-75.8%$25.81M$225,000.00-0.9034News CoverageGap DownPYPDPolyPid2.638 of 5 stars$2.41-4.0%$11.33+370.3%-38.3%$24.56MN/A-0.4880Short Interest ↓Analyst RevisionNews Coverage Related Companies and Tools Related Companies Daxor Competitors Safe Pro Group Inc. Common Stock Competitors Outset Medical Competitors Modular Medical Competitors Precision Optics Competitors Femasys Competitors CollPlant Biotechnologies Competitors Spectral AI Competitors Envoy Medical Competitors PolyPid Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.